Previous Issues

In This Issue

• Merck to Acquire Schering-Plough in $41 Billion Deal - Read the full story . . .
• Roche Agrees to Buy Genentech for $47 Billion - Read the full story . . .
• Pfizer Acquiring Wyeth in $68 Billion Deal - Read the full story . . .
• GTC Wins Approval for Drug Produced using Genetically Modified Animals - Read the full story . . .
• Targanta to be Acquired for $133M - Read the full story . . .
• Biogen Idec Talking with MS Pill Maker - Read the full story . . .
• Massachusetts Life Sciences Center Names Winners of First Grants - Read the full story . . .
• Proteon Raises $38 Million in Finance Round - Read the full story . . .
• Altus Cuts Staff by 75 Percent, Drops Cystic Fibrosis Drug - Read the full story . . .
• Dynogen Pharmaceuticals Seeks Bankruptcy Protection - Read the full story . . .
• Panacos Cuts Jobs, Weighs Possible Sale - Read the full story . . .
• Innovative Spinal Technologies Closes - Read the full story . . .
• Sepracor to Shift Focus, Cut 530 Jobs - Read the full story . . .
• Vertex Founder Joshua Boger Stepping Down - Read the full story . . .
• Massachusetts Life Science Innovation Stats Dipped in 2007 - Read the full story . . .
• FDA Won't Sign Off on Genzyme Plan for Lumizyme Yet - Read the full story . . .
• Genzyme on the Hunt for New Products - Read the full story . . .
• Exact Sciences Works a $24 Million Partnership with Genzyme - Read the full story . . .

• Executive Order Removes Barriers to Human Stem Cell Research - Read the full story . . .
• Bill Backs Copies of Biotech Drugs - Read the full story . . .
• President Obama Announces Key FDA Appointments - Read the full story . . .
• FDA Launches Program to Improve the Safety of Drugs Produced Outside the US - Read the full story . . .
• FDA Panel Backs Lilly Blood-Thinner - Read the full story . . .
• City of Woburn Sets New Rules for Biotech - Read the full story . . .
• FDA Takes New Regulatory Action Against Ranbaxy - Read the full story . . .
• Cardinal Health Signs Amended Consent Decree with FDA - Read the full story . . .
• FDA Issues Public Health Advisory Concerning Genentech's Raptiva - Read the full story . . .
• FDA Approves Takeda's Uloric for Gout Management - Read the full story . . .
• FDA and International Consortium Release First Data on Genetic Basis of Adverse Drug Events - Read the full story . . .
• FDA Posts Quarterly Reports of Potential Drug Safety Issues - Read the full story . . .
• FDA Approves First Ablation Catheters for Atrial Fibrillation - Read the full story . . .
• FDA Issues Final Guidance on Regulating Genetically Engineered Animals - Read the full story . . .